Europe Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

The Europe Anxiety Disorders And Depression Treatment Market would witness market growth of 3.1% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Anxiety Disorders And Depression Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,029.4 million by 2031. The UK market is exhibiting a CAGR of 2.3% during (2024 - 2031). Additionally, The France market would exhibit a CAGR of 3.9% during (2024 - 2031).

The development of new and more effective antidepressants and anxiolytics, with improved safety profiles and fewer side effects, has expanded treatment options for patients. Adopting digital mental health solutions, including mobile therapy and mood-tracking apps, has made treatment more accessible and convenient.

Additionally, many healthcare providers now include mental health screenings as part of routine medical check-ups, which has led to early identification and intervention for anxiety and depression. Programs focusing on early intervention and preventive care have increased the adoption of treatments before conditions become severe.

The rising cases of depression and anxiety among European workers drive companies to implement or expand workplace mental health programs. This creates increased demand for mental health resources, employee assistance programs (EAPs), and counselling services designed to support affected employees. As per the European Council, in 2022, 27% of workers in Europe experienced stress, depression, or anxiety. Additionally, there was a 22% rise in loneliness across the E.U. following the COVID-19 pandemic.

Free Valuable Insights: The Global Anxiety Disorders And Depression Treatment Market will Hit USD 15.7 Billion by 2031, at a CAGR of 3.5%

Based on Indication, the market is segmented into Anxiety and Depression. Based on Drugs, the market is segmented into Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Pfizer Inc.
• GlaxoSmithKline PLC (GSK)
• Merck & Co., Inc.
• Eli Lilly And Company
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• Johnson & Johnson
• AbbVie Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited

Europe Anxiety Disorders And Depression Treatment Market Report Segmentation

By Indication

• Anxiety
• Depression

By Drugs

• Antidepressants
• Anxiolytics
• Anticonvulsants
• Noradrenergic Agents
• Atypical Antipsychotics

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Anxiety Disorders And Depression Treatment Market, by Indication
1.4.2 Europe Anxiety Disorders And Depression Treatment Market, by Drugs
1.4.3 Europe Anxiety Disorders And Depression Treatment Market, by Distribution Channel
1.4.4 Europe Anxiety Disorders And Depression Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Anxiety Disorders And Depression Treatment Market by Indication
4.1 Europe Anxiety Market by Country
4.2 Europe Depression Market by Country

Chapter 5. Europe Anxiety Disorders And Depression Treatment Market by Drugs
5.1 Europe Antidepressants Market by Country
5.2 Europe Anxiolytics Market by Country
5.3 Europe Anticonvulsants Market by Country
5.4 Europe Noradrenergic Agents Market by Country
5.5 Europe Atypical Antipsychotics Market by Country

Chapter 6. Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
6.1 Europe Retail Pharmacies Market by Country
6.2 Europe Hospital Pharmacies Market by Country
6.3 Europe Online Pharmacies Market by Country

Chapter 7. Europe Anxiety Disorders And Depression Treatment Market by Country
7.1 Germany Anxiety Disorders And Depression Treatment Market
7.1.1 Germany Anxiety Disorders And Depression Treatment Market by Indication
7.1.2 Germany Anxiety Disorders And Depression Treatment Market by Drugs
7.1.3 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2 UK Anxiety Disorders And Depression Treatment Market
7.2.1 UK Anxiety Disorders And Depression Treatment Market by Indication
7.2.2 UK Anxiety Disorders And Depression Treatment Market by Drugs
7.2.3 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3 France Anxiety Disorders And Depression Treatment Market
7.3.1 France Anxiety Disorders And Depression Treatment Market by Indication
7.3.2 France Anxiety Disorders And Depression Treatment Market by Drugs
7.3.3 France Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4 Russia Anxiety Disorders And Depression Treatment Market
7.4.1 Russia Anxiety Disorders And Depression Treatment Market by Indication
7.4.2 Russia Anxiety Disorders And Depression Treatment Market by Drugs
7.4.3 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.5 Spain Anxiety Disorders And Depression Treatment Market
7.5.1 Spain Anxiety Disorders And Depression Treatment Market by Indication
7.5.2 Spain Anxiety Disorders And Depression Treatment Market by Drugs
7.5.3 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.6 Italy Anxiety Disorders And Depression Treatment Market
7.6.1 Italy Anxiety Disorders And Depression Treatment Market by Indication
7.6.2 Italy Anxiety Disorders And Depression Treatment Market by Drugs
7.6.3 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.7 Rest of Europe Anxiety Disorders And Depression Treatment Market
7.7.1 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication
7.7.2 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs
7.7.3 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Merck & Co., Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Eli Lilly And Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 AstraZeneca PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Bristol-Myers Squibb Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 AbbVie, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Takeda Pharmaceutical Company Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

TABLE 1 Europe Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 2 Europe Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 3 Europe Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 4 Europe Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 5 Europe Anxiety Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Anxiety Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Depression Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Depression Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 10 Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 11 Europe Antidepressants Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Antidepressants Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe Anxiolytics Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Anxiolytics Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Anticonvulsants Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Anticonvulsants Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Noradrenergic Agents Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Noradrenergic Agents Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Atypical Antipsychotics Market by Country, 2020 - 2023, USD Million
TABLE 20 Europe Atypical Antipsychotics Market by Country, 2024 - 2031, USD Million
TABLE 21 Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 22 Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 23 Europe Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Online Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Online Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Anxiety Disorders And Depression Treatment Market by Country, 2024 - 2031, USD Million
TABLE 31 Germany Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 32 Germany Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 33 Germany Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 34 Germany Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 35 Germany Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 36 Germany Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 37 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 38 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 39 UK Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 40 UK Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 41 UK Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 42 UK Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 43 UK Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 44 UK Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 45 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 46 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 47 France Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 48 France Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 49 France Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 50 France Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 51 France Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 52 France Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 53 France Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 54 France Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 55 Russia Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 56 Russia Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 57 Russia Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 58 Russia Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 59 Russia Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 60 Russia Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 61 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 62 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 63 Spain Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 64 Spain Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 65 Spain Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 66 Spain Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 67 Spain Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 68 Spain Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 69 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 70 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 71 Italy Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 72 Italy Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 73 Italy Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 74 Italy Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 75 Italy Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 76 Italy Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 77 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 Rest of Europe Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 80 Rest of Europe Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 81 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 82 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 83 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 84 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 85 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 86 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 87 Key Information – Pfizer, Inc.
TABLE 88 Key Information – GlaxoSmithKline PLC
TABLE 89 Key Information - Merck & Co., Inc.
TABLE 90 Key Information – Eli Lilly And Company
TABLE 91 Key Information – AstraZeneca PLC
TABLE 92 Key Information – Bristol-Myers Squibb Company
TABLE 93 Key Information – Johnson & Johnson
TABLE 94 Key information – AbbVie, Inc.
TABLE 95 Key Information – Sanofi S.A.
TABLE 96 Key Information – Takeda Pharmaceutical Company Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Anxiety Disorders And Depression Treatment Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Anxiety Disorders And Depression Treatment Market
FIG 4 Porter’s Five Forces Analysis – Anxiety Disorders And Depression Treatment Market
FIG 5 Europe Anxiety Disorders And Depression Treatment Market share by Indication, 2023
FIG 6 Europe Anxiety Disorders And Depression Treatment Market share by Indication, 2031
FIG 7 Europe Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2031, USD Million
FIG 8 Europe Anxiety Disorders And Depression Treatment Market share by Drugs, 2023
FIG 9 Europe Anxiety Disorders And Depression Treatment Market share by Drugs, 2031
FIG 10 Europe Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2031, USD Million
FIG 11 Europe Anxiety Disorders And Depression Treatment Market share by Distribution Channel, 2023
FIG 12 Europe Anxiety Disorders And Depression Treatment Market share by Distribution Channel, 2031
FIG 13 Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2031, USD Million
FIG 14 Europe Anxiety Disorders And Depression Treatment Market share by Country, 2023
FIG 15 Europe Anxiety Disorders And Depression Treatment Market share by Country, 2031
FIG 16 Europe Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Pfizer, Inc.
FIG 18 SWOT Analysis: GlaxoSmithKline PLC
FIG 19 SWOT Analysis: Merck & Co., Inc.
FIG 20 Swot Analysis: Eli Lilly And Company
FIG 21 SWOT Analysis: AstraZeneca PLC
FIG 22 SWOT Analysis: Bristol-Myers Squibb Company
FIG 23 SWOT Analysis: Johnson & Johnson
FIG 24 Swot Analysis: AbbVie, Inc.
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis:Takeda Pharmaceutical Company Limited